“Bioactive Secondary Metabolites to Combat Diabetic Complications: Evidenced from in Silico Study”, Bangla Pharma J, vol. 26, no. 2, pp. 167–184, Aug. 2023, doi: 10.3329/bpj.v26i2.67807.